These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 3466738

  • 1. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.
    Pernow J, Lundberg JM, Kaijser L, Hjemdahl P, Theodorsson-Norheim E, Martinsson A, Pernow B.
    Clin Physiol; 1986 Dec; 6(6):561-78. PubMed ID: 3466738
    [Abstract] [Full Text] [Related]

  • 2. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man.
    Morris MJ, Russell AE, Kapoor V, Cain MD, Elliott JM, West MJ, Wing LM, Chalmers JP.
    J Auton Nerv Syst; 1986 Oct; 17(2):143-9. PubMed ID: 3782722
    [Abstract] [Full Text] [Related]

  • 3. Neuropeptide Y is released together with noradrenaline from the human heart during exercise and hypoxia.
    Kaijser L, Pernow J, Berglund B, Lundberg JM.
    Clin Physiol; 1990 Mar; 10(2):179-88. PubMed ID: 2318028
    [Abstract] [Full Text] [Related]

  • 4. Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans.
    Pernow J, Lundberg JM, Kaijser L.
    J Cardiovasc Pharmacol; 1988 Mar; 12(5):593-9. PubMed ID: 2468060
    [Abstract] [Full Text] [Related]

  • 5. Elevations of neuropeptide Y-like immunoreactivity and catecholamines in plasma on increased intracranial pressure in the pig.
    Rudehill A, Lundberg JM, Sollevi A, Hjemdahl P.
    Acta Anaesthesiol Scand; 1987 Feb; 31(2):132-8. PubMed ID: 3564869
    [Abstract] [Full Text] [Related]

  • 6. Neuropeptide Y in the sympathetic control of blood pressure in hypertensive subjects.
    Chalmers J, Morris M, Kapoor V, Cain M, Elliott J, Russell A, Pilowsky P, Minson J, West M, Wing L.
    Clin Exp Hypertens A; 1989 Feb; 11 Suppl 1():59-66. PubMed ID: 2743605
    [Abstract] [Full Text] [Related]

  • 7. Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat.
    Lundberg JM, Fried G, Pernow J, Theodorsson-Norheim E.
    Acta Physiol Scand; 1986 Feb; 126(2):231-8. PubMed ID: 3754683
    [Abstract] [Full Text] [Related]

  • 8. Effects of vinblastine on neuropeptide Y levels in the sympathoadrenal system, bone marrow and thrombocytes of the rat.
    Hemsén A, Pernow J, Millberg BI, Lundberg JM.
    Agents Actions; 1991 Nov; 34(3-4):429-38. PubMed ID: 1810152
    [Abstract] [Full Text] [Related]

  • 9. Neuropeptide Y and sympathetic vascular control in man.
    Lundberg JM, Torssell L, Sollevi A, Pernow J, Theodorsson Norheim E, Anggård A, Hamberger B.
    Regul Pept; 1985 Dec; 13(1):41-52. PubMed ID: 3841402
    [Abstract] [Full Text] [Related]

  • 10. Splanchnic release of neuropeptide Y during prolonged exercise with and without beta-adrenoceptor blockade in healthy man.
    Ahlborg G, Lundberg JM.
    Clin Physiol; 1991 Jul; 11(4):343-51. PubMed ID: 1680600
    [Abstract] [Full Text] [Related]

  • 11. The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA and neuropeptide Y-like immunoreactivity in normal human subjects.
    Hetland ML, Eldrup E, Bratholm P, Christensen NJ.
    Scand J Clin Lab Invest; 1991 May; 51(3):219-24. PubMed ID: 1909048
    [Abstract] [Full Text] [Related]

  • 12. Increased plasma levels of neuropeptide Y-like immunoreactivity and catecholamines in severe hypertension remain after treatment to normotension in man.
    Edvinsson L, Ekman R, Thulin T.
    Regul Pept; 1991 Feb 26; 32(3):279-87. PubMed ID: 1866472
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J.
    Acta Physiol Scand Suppl; 1988 Feb 26; 568():1-56. PubMed ID: 3232527
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evidence for co-transmitter role of neuropeptide Y in the pig spleen.
    Lundberg JM, Rudehill A, Sollevi A, Hamberger B.
    Br J Pharmacol; 1989 Mar 26; 96(3):675-87. PubMed ID: 2566349
    [Abstract] [Full Text] [Related]

  • 20. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man.
    Pernow J, Lundberg JM, Kaijser L.
    Life Sci; 1987 Jan 05; 40(1):47-54. PubMed ID: 3796213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.